← Voltar para CVEs
CVE-2020-3950
HIGHCISA KEV7.8
Descricao
VMware Fusion (11.x before 11.5.2), VMware Remote Console for Mac (11.x and prior before 11.0.1) and Horizon Client for Mac (5.x and prior before 5.4.0) contain a privilege escalation vulnerability due to improper use of setuid binaries. Successful exploitation of this issue may allow attackers with normal user privileges to escalate their privileges to root on the system where Fusion, VMRC or Horizon Client is installed.
Detalhes CVE
Pontuacao CVSS v3.17.8
SeveridadeHIGH
Vetor CVSSCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Vetor de ataqueLOCAL
ComplexidadeLOW
Privilegios necessariosLOW
Interacao do usuarioNONE
Publicado3/17/2020
Ultima modificacao10/30/2025
Fontekev
Avistamentos honeypot0
CISA KEV
FornecedorVMware
ProdutoMultiple Products
Nome da vulnerabilidadeVMware Multiple Products Privilege Escalation Vulnerability
Data inclusao KEV2021-11-03
Prazo de remediacao2022-05-03
Uso em ransomwareUnknown
Produtos afetados
apple:macosvmware:fusionvmware:horizon_clientvmware:remote_console
Fraquezas (CWE)
CWE-269CWE-269
Referencias
http://packetstormsecurity.com/files/156843/VMware-Fusion-11.5.2-Privilege-Escalation.html(security@vmware.com)
http://packetstormsecurity.com/files/157079/VMware-Fusion-USB-Arbitrator-Setuid-Privilege-Escalation.html(security@vmware.com)
https://www.vmware.com/security/advisories/VMSA-2020-0005.html(security@vmware.com)
http://packetstormsecurity.com/files/156843/VMware-Fusion-11.5.2-Privilege-Escalation.html(af854a3a-2127-422b-91ae-364da2661108)
http://packetstormsecurity.com/files/157079/VMware-Fusion-USB-Arbitrator-Setuid-Privilege-Escalation.html(af854a3a-2127-422b-91ae-364da2661108)
https://www.vmware.com/security/advisories/VMSA-2020-0005.html(af854a3a-2127-422b-91ae-364da2661108)
https://www.cisa.gov/known-exploited-vulnerabilities-catalog?field_cve=CVE-2020-3950(134c704f-9b21-4f2e-91b3-4a467353bcc0)
Correlacoes IOC
Sem correlacoes registradas
This product uses data from the NVD API but is not endorsed or certified by the NVD.